Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) is now available.
Ind-Swift Laboratories Ltd. announced the approval of its audited financial results for the fourth quarter and fiscal year ending March 31, 2025, during a board meeting held on August 11, 2025. The results, reviewed by the Audit Committee and audited by Rattan Kaur & Associates, reflect the company’s financial performance post-merger with Ind Swift Limited. Additionally, the board approved the allotment and redemption of 1% Redeemable Preference Shares as part of the amalgamation scheme. These developments are expected to impact the company’s financial structure and stakeholder interests positively.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and finished dosage forms. The company is known for its emphasis on research and development, catering to both domestic and international markets.
Average Trading Volume: 32,539
Technical Sentiment Signal: Buy
Current Market Cap: 6.05B INR
For a thorough assessment of INDSWFTLAB stock, go to TipRanks’ Stock Analysis page.